The modern marketing maze

Marketing in our industry is not for the faint-hearted, although it is an area where dynamic teams can discover communicative muscles they never knew they had. As digital possibilities emerge at pace, the modern marketing maze offers exciting opportunities, but identifying them amid regulation and digital domination presents a formidable set of challenges. Challenges which, curiously, many relish...
Pharmaceutical pricing - it’s political

Dr Joe Zammit-Lucia on why it is becoming increasingly import for pharma companies to develop new approaches to pricing that have political resonance
The Plan in action

Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the seismic changes that have been occurring in the NHS since the Long Term Plan was published

News

View all

EMA accepts license extension submission for Invokana and Vokanamet

The decision is based on results from the landmark Phase III CREDENCE study

23rd August 2019

Multiple antibiotic courses linked to pediatric treatment failure

Data showed that those who had been given at least two previous courses were 32% more likely to fail to respond to a subsequent course.

23rd August 2019

NICE recommends antiseptics over antibiotics for impetigo

Antiseptic such as hydrogen peroxide 1% cream is ‘just as effective’ as a topical antibiotic.

23rd August 2019

HSE reimburses Braftovi combo

Eligible patients in the Republic of Ireland can potentially benefit from the combination with immediate effect.

23rd August 2019

One in seven five-year-olds don’t have MMR jabs

The lack of immunisation leaves children at high risk of measles at a time when outbreaks of the disease are occurring across the country.

23rd August 2019

Web Exclusives

View all

ISO IDMP has resumed central focus at EMA, so life sciences firms must step up their own activities if they are to achieve compliance in their marketing submissions by the expected deadline of 2021. AMPLEXOR’s Siniša Belina explores the best approach to maximising returns over the long term.

KAM for pharma

KAM principles translate across all business sectors. David Southern and Gary Lunt describe six steps for learning the best from other sectors.

Keeping pharmaceuticals moving post-Brexit

Advice from Tim Harding, customs and tax manager at GEFCO UK, on how to keep medicines moving after the UK departs from the European Union.

Industry's adoption of natural language processing

Adoption of natural language processing and text analytic technologies across healthcare and life science organisations looks set to accelerate with explosive growth in unstructured data and the growing need to gain relevant insight from it.

Magazine

View more from the latest edition

Patient Files: prostate cancer

Chris James shares his experiences with different treatments for testicular and prostate cancer

SmartPeople: James Merson

James Merson, global therapeutic area head for Infectious Diseases at Janssen Research & Development, believes that through continued advancements in science “we can change the trajectory of health for humanity and strive to make infectious diseases an issue of the past”

Pharmaceutical pricing - it’s political

Dr Joe Zammit-Lucia on why it is becoming increasingly import for pharma companies to develop new approaches to pricing that have political resonance

Company Focus: MedPharm

Jeremy Drummond, senior vice president of Business Development at MedPharm, on the challenges and opportunities of topical delivery

Connected labelling - the final frontier?

However much progress life sciences companies have made in bringing their regulatory information under control, labelling management continues to overshadow these accomplishments. Too often labelling is disconnected from other systems, forcing heavy reliance on manual processes and checks which in turn can cause hold-ups and create an undesirable source of risk, especially across country borders. Agnes Cwienczek delves deeper into the issues and potential remedies

The modern marketing maze

Marketing in our industry is not for the faint-hearted, although it is an area where dynamic teams can discover communicative muscles they never knew they had. As digital possibilities emerge at pace, the modern marketing maze offers exciting opportunities, but identifying them amid regulation and digital domination presents a formidable set of challenges. Challenges which, curiously, many relish...

The promised land?

Brexit was supposed to be an opportunity for the UK to strike trade deals outside the EU, but the going is tough

A true partnership

Michael Goetzl says it’s time for industry to work in true partnership with health systems “at every step of the way” to speed up access to innovation